Defronzo R - Search Results

1

Personalized management of hyperglycemia in type 2 diabetes: reflections from a Diabetes Care Editors' Expert Forum.

Raz I, Riddle MC, Rosenstock J, Buse JB, Inzucchi SE, Home PD, Del Prato S, Ferrannini E, Chan JC, Leiter LA, Leroith D, Defronzo R, Cefalu WT. Raz I, et al. Among authors: defronzo r. Diabetes Care. 2013 Jun;36(6):1779-88. doi: 10.2337/dc13-0512. Diabetes Care. 2013. PMID: 23704680 Free PMC article.

2

The A1C and ABCD of glycaemia management in type 2 diabetes: a physician's personalized approach.

Pozzilli P, Leslie RD, Chan J, De Fronzo R, Monnier L, Raz I, Del Prato S. Pozzilli P, et al. Diabetes Metab Res Rev. 2010 May;26(4):239-44. doi: 10.1002/dmrr.1092. Diabetes Metab Res Rev. 2010. PMID: 20503255 Review.

3

Association of Baseline Characteristics With Insulin Sensitivity and β-Cell Function in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) Study Cohort.

Rasouli N, Younes N, Utzschneider KM, Inzucchi SE, Balasubramanyam A, Cherrington AL, Ismail-Beigi F, Cohen RM, Olson DE, DeFronzo RA, Herman WH, Lachin JM, Kahn SE; GRADE Research Group. Rasouli N, et al. Diabetes Care. 2021 Feb;44(2):340-349. doi: 10.2337/dc20-1787. Epub 2020 Dec 17. Diabetes Care. 2021. PMID: 33334808 Free PMC article.

4

Rationale and design of the glycemia reduction approaches in diabetes: a comparative effectiveness study (GRADE).

Nathan DM, Buse JB, Kahn SE, Krause-Steinrauf H, Larkin ME, Staten M, Wexler D, Lachin JM; GRADE Study Research Group. Nathan DM, et al. Diabetes Care. 2013 Aug;36(8):2254-61. doi: 10.2337/dc13-0356. Epub 2013 May 20. Diabetes Care. 2013. PMID: 23690531 Free PMC article. Clinical Trial.

5

Insulin resistance and diabetes mellitus.

DeFronzo RA, Del Prato S. DeFronzo RA, et al. J Diabetes Complications. 1996 Sep-Oct;10(5):243-5. doi: 10.1016/1056-8727(96)00046-3. J Diabetes Complications. 1996. PMID: 8887011 Review. No abstract available.

6

Pathogenesis of NIDDM. A balanced overview.

DeFronzo RA, Bonadonna RC, Ferrannini E. DeFronzo RA, et al. Diabetes Care. 1992 Mar;15(3):318-68. doi: 10.2337/diacare.15.3.318. Diabetes Care. 1992. PMID: 1532777

7

Bedtime insulin/daytime glipizide. Effective therapy for sulfonylurea failures in NIDDM.

Shank ML, Del Prato S, DeFronzo RA. Shank ML, et al. Among authors: defronzo ra. Diabetes. 1995 Feb;44(2):165-72. doi: 10.2337/diab.44.2.165. Diabetes. 1995. PMID: 7859936 Clinical Trial.

8

The role of the kidneys in glucose homeostasis: a new path towards normalizing glycaemia.

DeFronzo RA, Davidson JA, Del Prato S. DeFronzo RA, et al. Diabetes Obes Metab. 2012 Jan;14(1):5-14. doi: 10.1111/j.1463-1326.2011.01511.x. Diabetes Obes Metab. 2012. PMID: 21955459 Review.

9

The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents.

Gulli G, Ferrannini E, Stern M, Haffner S, DeFronzo RA. Gulli G, et al. Among authors: defronzo ra. Diabetes. 1992 Dec;41(12):1575-86. doi: 10.2337/diab.41.12.1575. Diabetes. 1992. PMID: 1446799

10

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease.

DeFronzo RA, Ferrannini E. DeFronzo RA, et al. Diabetes Care. 1991 Mar;14(3):173-94. doi: 10.2337/diacare.14.3.173. Diabetes Care. 1991. PMID: 2044434 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

760 results

Search Page